Available COVID-19 vaccines effective against variants
The Food and Drug Administration (FDA) reassures the public that COVID-19 vaccines are effective against various virus variants, including Delta [4].
Currently, the country uses four vaccine brands: AstraZeneca, Pfizer, Sinovac, and Sputnik V. Among these brands, DFA Director-General Eric Domingo said that AstraZeneca and Pfizers are found effective against new variants based on data from the United Kingdom, where the new variants are prominent.
In addition, AstraZeneca has a 60% efficacy rate against the Delta variant and a 66% efficacy rate against the Alpha variant. For Pfizer, studies found that the vaccine has 93% efficacy against the Alpha variant and 88% against the Delta variant.
As for the remaining brands, ongoing studies have yet to determine their efficacy.
Midnight vaccination starts in Taguig.
Taguig City starts its 24-operations in vaccination hubs to accommodate more residents. The vaccination hub will cover those under the A4 priority group, economic frontliners, and government workers [5].
Since the schedule will go beyond curfew hours, residents are reassured that they would not be apprehended as long as they show their appointment slips to enforcers. Before going to the vaccination sites, residents must set appointments via Taguig Registry for Access and Citizen Engagement (TRACE). Those who do not have quick access to the internet can use kiosks set up in villages and selected malls.
All details and information in this article are true and accurate as of the publication date. However, while we are making our utmost effort to keep our content as up-to-date as possible, the condition surrounding the COVID-19 pandemic continues to be unpredictable, and the situation develops rapidly. Hence, some information and recommendations may have changed since this article was published. For the latest advice, visit DOH and your LGU's official websites.
Sources:
[1] https://bit.ly/3hrNrew
[2] https://bit.ly/2V0qrMp
[3] https://bit.ly/3qBG0FK
[4] https://bit.ly/3xaDrx2
[5] https://bit.ly/3h8gtkr
Check out this video: